ArticleBlood research2025

Improved survival in pediatric acute lymphoblastic leukemia through therapy intensification based on minimal residual disease and protocol-driven early response risk classification.

Hyery Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.